Tamoxifen Exposure during Pregnancy : A Systematic Review and Three More Cases
Copyright © 2019 by S. Karger AG, Basel..
Tamoxifen is frequently used as adjuvant treatment in premenopausal patients with hormone receptor-positive early breast cancer. According to guidelines, the use of nonhormonal barrier contraception is recommended during tamoxifen treatment and up to 3 months after its interruption prior to attempting conception. Nevertheless, when conception occurs inadvertently during tamoxifen treatment, the effects on the fetus and on the course of pregnancy are still not completely known. Here, we report 3 cases of young women who accidentally became pregnant while taking tamoxifen and perform a systematic review of the literature to provide more elements for better and clear multidisciplinary counselling of women facing this challenging situation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Breast care (Basel, Switzerland) - 15(2020), 2 vom: 12. Apr., Seite 148-156 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Buonomo, Barbara [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Breast cancer |
|---|
| Anmerkungen: |
Date Revised 02.04.2021 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1159/000501473 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309820049 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309820049 | ||
| 003 | DE-627 | ||
| 005 | 20231225134742.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000501473 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1032.xml |
| 035 | |a (DE-627)NLM309820049 | ||
| 035 | |a (NLM)32398983 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Buonomo, Barbara |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tamoxifen Exposure during Pregnancy |b A Systematic Review and Three More Cases |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 02.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2019 by S. Karger AG, Basel. | ||
| 520 | |a Tamoxifen is frequently used as adjuvant treatment in premenopausal patients with hormone receptor-positive early breast cancer. According to guidelines, the use of nonhormonal barrier contraception is recommended during tamoxifen treatment and up to 3 months after its interruption prior to attempting conception. Nevertheless, when conception occurs inadvertently during tamoxifen treatment, the effects on the fetus and on the course of pregnancy are still not completely known. Here, we report 3 cases of young women who accidentally became pregnant while taking tamoxifen and perform a systematic review of the literature to provide more elements for better and clear multidisciplinary counselling of women facing this challenging situation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Breast cancer | |
| 650 | 4 | |a Breast carcinoma | |
| 650 | 4 | |a Pregnancy | |
| 650 | 4 | |a Tamoxifen | |
| 650 | 4 | |a Teratogenic effects | |
| 700 | 1 | |a Brunello, Antonella |e verfasserin |4 aut | |
| 700 | 1 | |a Noli, Stefania |e verfasserin |4 aut | |
| 700 | 1 | |a Miglietta, Loredana |e verfasserin |4 aut | |
| 700 | 1 | |a Del Mastro, Lucia |e verfasserin |4 aut | |
| 700 | 1 | |a Lambertini, Matteo |e verfasserin |4 aut | |
| 700 | 1 | |a Peccatori, Fedro Alessandro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Breast care (Basel, Switzerland) |d 2008 |g 15(2020), 2 vom: 12. Apr., Seite 148-156 |w (DE-627)NLM201410389 |x 1661-3791 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2020 |g number:2 |g day:12 |g month:04 |g pages:148-156 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1159/000501473 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2020 |e 2 |b 12 |c 04 |h 148-156 | ||